THE GOOD SHROOM CO INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.125 CAD | -3.85% |
|
+4.17% | -26.47% |
| 27/03 | Good Shroom Swings to Profit in Fiscal Q2, Revenue Grows | MT |
| 27/03 | The Good Shroom Co Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 | CI |
Valuation
| Fiscal Period: July | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 7.982 | 3.161 | 8.536 |
| Enterprise Value (EV) 1 | 6.601 | 2.617 | 8.231 |
| P/E ratio | -1.68 x | -1.94 x | -19 x |
| Yield | - | - | - |
| Capitalization / Revenue | 3,29,65,572 x | 26,01,050 x | 26,98,550 x |
| EV / Revenue | 2,72,62,483 x | 21,53,543 x | 26,02,324 x |
| EV / EBITDA | -30,51,005 x | -16,72,998 x | -1,97,37,444 x |
| EV / FCF | -71,76,146 x | -1,29,44,075 x | -5,38,47,294 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 4.42 x | 4.16 x | 19.3 x |
| Nbr of stocks (in thousands) | 48,375 | 48,625 | 48,775 |
| Reference price 2 | 0.1650 | 0.0650 | 0.1750 |
| Announcement Date | 29/11/21 | 22/11/22 | 27/11/23 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: July | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net sales | - | 0.1969 | 0.2421 | 1.215 | 3.163 |
| EBITDA | - | -0.3786 | -2.164 | -1.564 | -0.417 |
| EBIT 1 | -0.2063 | -0.3817 | -2.168 | -1.571 | -0.4243 |
| Operating Margin | - | -193.82% | -895.35% | -129.32% | -13.41% |
| Earnings before Tax (EBT) 1 | -0.2069 | -0.4196 | -3.849 | -1.629 | -0.4521 |
| Net income 1 | -0.1823 | -0.4196 | -3.849 | -1.629 | -0.4521 |
| Net margin | - | -213.08% | -1,589.86% | -134.06% | -14.29% |
| EPS | - | - | -0.0983 | -0.0335 | -0.009200 |
| Free Cash Flow | - | -0.6145 | -0.9198 | -0.2022 | -0.1529 |
| FCF margin | - | -312.06% | -379.9% | -16.64% | -4.83% |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 13/04/21 | 13/04/21 | 29/11/21 | 22/11/22 | 27/11/23 |
1CAD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: Juli | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 0.21 | - | - | - |
| Net Cash position 1 | 0 | - | 1.38 | 0.54 | 0.3 |
| Leverage (Debt/EBITDA) | - | -0.5533 x | - | - | - |
| Free Cash Flow | - | -0.61 | -0.92 | -0.2 | -0.15 |
| ROE (net income / shareholders' equity) | - | 245% | -451% | -127% | -74.1% |
| ROA (Net income/ Total Assets) | - | -50.9% | -89.5% | -49.8% | -17.2% |
| Assets 1 | - | 0.8236 | 4.302 | 3.271 | 2.633 |
| Book Value Per Share | - | - | 0.0400 | 0.0200 | 0.0100 |
| Cash Flow per Share | - | - | 0.0300 | 0.0100 | 0.0100 |
| Capex 1 | 0.03 | 0 | 0.02 | - | - |
| Capex / Sales | - | 0.52% | 8.54% | - | - |
| Announcement Date | 13/04/21 | 13/04/21 | 29/11/21 | 22/11/22 | 27/11/23 |
1CAD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -26.47% | 48.48L | |
| +16.86% | 847.6Cr | |
| +6.26% | 759.52Cr | |
| +4.89% | 638.54Cr | |
| -5.63% | 374.96Cr | |
| -6.58% | 370.82Cr | |
| -3.55% | 135.51Cr | |
| -28.90% | 110.76Cr | |
| +18.12% | 102.38Cr | |
| -8.94% | 92Cr |
- Stock Market
- Equities
- MUSH Stock
- Financials The Good Shroom Co Inc.